Wesana Health Holdings Inc. (WSNAF)
USD 0.0
(-48.0%)
USD 0.0
(-48.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.05 Million USD | 60.83% |
| 2022 | -2.87 Million USD | 78.8% |
| 2021 | -4.67 Million USD | -15437.45% |
| 2020 | -87.18 Thousand USD | 14.86% |
| 2019 | -101.53 Thousand USD | -154.79% |
| 2018 | -40.18 Thousand USD | 0.0% |
| 2015 | -66.9 Thousand USD | 61.03% |
| 2014 | -171.69 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -103.93 Thousand USD | -69.18% |
| 2024 Q2 | -157.2 Thousand USD | 7.67% |
| 2023 FY | - USD | 60.83% |
| 2023 Q4 | -166.3 Thousand USD | 10.53% |
| 2023 Q1 | -445.82 Thousand USD | 27.59% |
| 2023 Q2 | -375.77 Thousand USD | 15.71% |
| 2023 Q3 | -185.87 Thousand USD | 50.53% |
| 2022 FY | - USD | 78.8% |
| 2022 Q4 | -615.68 Thousand USD | -189.03% |
| 2022 Q3 | 691.57 Thousand USD | 121.4% |
| 2022 Q2 | -3.23 Million USD | 29.12% |
| 2022 Q1 | -4.55 Million USD | 15.91% |
| 2021 Q3 | -4.04 Million USD | -52.66% |
| 2021 FY | - USD | -15437.45% |
| 2021 Q4 | -5.42 Million USD | -33.97% |
| 2021 Q1 | -1.42 Million USD | -2686.54% |
| 2021 Q2 | -2.65 Million USD | -85.98% |
| 2020 Q1 | -468.00 USD | 0.0% |
| 2020 Q4 | -51.15 Thousand USD | -81.68% |
| 2020 Q3 | -28.15 Thousand USD | -280.38% |
| 2020 Q2 | -7402.00 USD | -1481.62% |
| 2020 FY | - USD | 14.86% |
| 2019 FY | - USD | -154.79% |
| 2018 FY | - USD | 0.0% |
| 2015 FY | - USD | 61.03% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 97.104% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | 65.306% |
| SQZ Biotechnologies Company | -64.14 Million USD | 96.793% |
| Evofem Biosciences, Inc. | -17.37 Million USD | 88.158% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 102.187% |
| Mesoblast Limited | -62.38 Million USD | 96.703% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -33.915% |
| Genus plc | 73.7 Million USD | 102.791% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | 68.888% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | 42.007% |
| Marizyme, Inc. | -34.28 Million USD | 94.0% |
| ContraFect Corporation | -64.99 Million USD | 96.835% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | 76.55% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | 54.553% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -46.739% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | 22.214% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | 11.482% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -297.069% |
| Accustem Sciences Inc. | -3.74 Million USD | 45.094% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 95.735% |
| EV Biologics, Inc. | -1.26 Million USD | -62.335% |
| Q BioMed Inc. | -617.62 Thousand USD | -233.048% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 157.587% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -225.266% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | 9.958% |
| Biomind Labs Inc. | -1.03 Million USD | -98.831% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 9.87 Million USD | 120.826% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | 71.276% |
| Skye Bioscience, Inc. | -13.54 Million USD | 84.816% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -38.294% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -8128.0% |
| Arch Therapeutics, Inc. | -3.88 Million USD | 47.043% |
| IMV Inc. | -35.52 Million USD | 94.209% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | 87.038% |
| Curative Biotechnology, Inc. | -2.5 Million USD | 17.785% |
| GB Sciences, Inc. | -1.41 Million USD | -44.871% |
| Alpha Cognition Inc. | -9.7 Million USD | 78.806% |
| HST Global, Inc. | -5303.00 USD | -38689.365% |
| CSL Limited | 4.78 Billion USD | 100.043% |
| Halberd Corporation | -74.27 Thousand USD | -2669.289% |
| Enzolytics Inc. | -2.12 Million USD | 3.064% |
| Resverlogix Corp. | -11.74 Million USD | 82.482% |
| Affymax, Inc. | -14.29 Million USD | 85.61% |
| SYBLEU INC | -141.57 Thousand USD | -1352.981% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | 32.844% |
| argenx SE | -216.02 Million USD | 99.048% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 96.283% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 269.022% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -37.233% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 642.968% |
| AVAX Technologies, Inc. | -6.11 Million USD | 66.348% |
| Zenith Capital Corp. | -8.6 Million USD | 76.098% |
| Genscript Biotech Corporation | -248.71 Million USD | 99.173% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -11707.589% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | 15.919% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -1068.588% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 94.81% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | 28.881% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.04 Million USD | -96.595% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 30691.91% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -17.543% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -7.085% |
| BioStem Technologies, Inc. | -7.55 Million USD | 72.768% |
| ONE Bio Corp. | 13.61 Million USD | 115.111% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -1035.912% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Agentix Corp. | -1.37 Million USD | -49.954% |
| LadRx Corporation | 412.28 Thousand USD | 598.929% |
| Cell Source, Inc. | -4.27 Million USD | 51.855% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -460.153% |
| Regen BioPharma, Inc. | 1.46 Million USD | 240.318% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -119.542% |
| NovAccess Global Inc. | -1.03 Million USD | -98.783% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 123.233% |
| Itoco Inc. | -1.86 Million USD | -10.059% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -441.858% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -84.319% |
| Kadimastem Ltd | -2.62 Million USD | 21.62% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -760.13% |
| CytoDyn Inc. | -18.02 Million USD | 88.591% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -2502.842% |
| Mobile Lads Corp. | -2.24 Million USD | 8.217% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -16720.672% |
| Qrons Inc. | -40.08 Thousand USD | -5032.107% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -323.532% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 490.002% |
| Rebus Holdings, Inc. | -951 Thousand USD | -116.299% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -93.689% |
| International Stem Cell Corporation | 202 Thousand USD | 1118.317% |
| Bioxytran, Inc. | -3.82 Million USD | 46.154% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -3807.675% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | 16.448% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 94.265% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -4471.111% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | 24.872% |
| Neutra Corp. | -181.24 Thousand USD | -1034.915% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 89.796% |
| PureTech Health plc | -11.62 Million USD | 82.308% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 89.795% |
| IXICO plc | -707 Thousand USD | -190.948% |
| IntelGenx Technologies Corp. | -7.68 Million USD | 73.234% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 95.745% |
| CSL Limited | 4.73 Billion USD | 100.043% |
| Cellectis S.A. | -92.63 Million USD | 97.779% |